These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3391372)

  • 21. Steroid therapy of chronic hepatitis: characteristics associated with response in anti-hepatitis C virus-positive and -negative patients.
    Thiele DL; DuCharme L; Cunningham MR; Mimms LT; Cuthbert JA; Lee WM; Combes B
    Am J Gastroenterol; 1996 Feb; 91(2):300-8. PubMed ID: 8607497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term corticosteroid therapy for chronic active hepatitis B.
    Laskus T; Cianciara J; Loch T; Slusarczyk J
    Digestion; 1990; 47(2):115-20. PubMed ID: 2292353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Autoimmune chronic active hepatitis: the potential need for long-term (life-long?) maintenance therapy].
    Bronkhorst CM; Brandt KH; van Berge Henegouwen GP
    Ned Tijdschr Geneeskd; 1991 Sep; 135(36):1617-20. PubMed ID: 1922495
    [No Abstract]   [Full Text] [Related]  

  • 24. [Autoimmune chronic active hepatitis: anatomoclinic's study of 50 patients].
    Hakem D; Berrah A; Berkane S; Asselah H; Aït-Younes S; Asselah F; Salah S; Merriche S; Abbadi MC
    Rev Med Interne; 2005 Nov; 26(11):858-65. PubMed ID: 16137797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features and prognosis of severe chronic active liver disease (CALD) after corticosteroid-induced remission.
    Czaja AJ; Ammon HV; Summerskill WH
    Gastroenterology; 1980 Mar; 78(3):518-23. PubMed ID: 7351290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis.
    Ichai P; Duclos-Vallée JC; Guettier C; Hamida SB; Antonini T; Delvart V; Saliba F; Azoulay D; Castaing D; Samuel D
    Liver Transpl; 2007 Jul; 13(7):996-1003. PubMed ID: 17370335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chronic active hepatitis in a 2 year-old boy: a probable case of autoimmune hepatitis without usually known autoantibodies?].
    Lachaux A; Le Gall C; Bouvier R; Hermier M
    Gastroenterol Clin Biol; 1993; 17(3):233-4. PubMed ID: 8330705
    [No Abstract]   [Full Text] [Related]  

  • 28. Exacerbation of chronic active hepatitis type B after short-term corticosteroid therapy resulting in fatal liver failure.
    Laskus T; Slusarczyk J; Cianciara J; Loch T
    Am J Gastroenterol; 1990 Oct; 85(10):1414-7. PubMed ID: 2220740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of steroid-based therapy for the hepatitis C-autoimmune hepatitis overlap syndrome.
    Schiano TD; Te HS; Thomas RM; Hussain H; Bond K; Black M
    Am J Gastroenterol; 2001 Oct; 96(10):2984-91. PubMed ID: 11693337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic hepatitis.
    Fitzgerald JF
    J Pediatr; 1984 Jun; 104(6):893-5. PubMed ID: 6233413
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug therapy in the management of type 1 autoimmune hepatitis.
    Czaja AJ
    Drugs; 1999 Jan; 57(1):49-68. PubMed ID: 9951951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of aetiology, clinical and histological features on survival in chronic active hepatitis: an analysis of 204 patients.
    Keating JJ; O'Brien CJ; Stellon AJ; Portmann BC; Johnson RD; Johnson PJ; Williams R
    Q J Med; 1987 Jan; 62(237):59-66. PubMed ID: 3423206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B.
    Perrillo RP; Regenstein FG; Bodicky CJ; Campbell CR; Sanders GE; Sunwoo YC
    Gastroenterology; 1985 Mar; 88(3):780-6. PubMed ID: 2578421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fulminant presentation of autoimmune hepatitis: clinical features and early predictors of corticosteroid treatment failure.
    Mendizabal M; Marciano S; Videla MG; Anders M; Zerega A; Balderramo DC; Tisi Baña MR; Barrabino M; Gil O; Mastai R; Yantorno S; Gadano A; Silva MO
    Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):644-8. PubMed ID: 25923939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequency and significance of immunoglobulin M antibody to hepatitis B core antigen in corticosteroid-treated severe chronic active hepatitis B.
    Czaja AJ; Shiels MT; Taswell HF; Wood JR; Ludwig J; Chase RC
    Mayo Clin Proc; 1988 Feb; 63(2):119-25. PubMed ID: 3339905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of hepatitis C virus antibody by first and second generation assays and polymerase chain reaction in patients with autoimmune chronic active hepatitis types I, II, and III.
    Mitchel LS; Jeffers LJ; Reddy KR; Cheinquer H; Coelho-Little E; Moreda R; Parker T; Silva M; Li XM; de Medina M
    Am J Gastroenterol; 1993 Jul; 88(7):1027-34. PubMed ID: 7686329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomised controlled trial of azathioprine withdrawal in autoimmune chronic active hepatitis.
    Stellon AJ; Hegarty JE; Portmann B; Williams R
    Lancet; 1985 Mar; 1(8430):668-70. PubMed ID: 2858619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Results and prognostic factors in the treatment of chronic active hepatitis with prednisone and azathioprine].
    Jorge AD; Sánchez D
    Acta Gastroenterol Latinoam; 1985; 15(4):233-41. PubMed ID: 3842554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ineffectiveness of corticosteroids in cholestatic forms of chronic active hepatitis].
    Degos F; Degott C; Erlinger S
    Gastroenterol Clin Biol; 1980 Apr; 4(4):246-50. PubMed ID: 7188271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 'Acute' autoimmune hepatitis.
    Crapper RM; Bhathal PS; Mackay IR; Frazer IH
    Digestion; 1986; 34(3):216-25. PubMed ID: 3758517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.